As of 2025-09-17, the Intrinsic Value of Evelo Biosciences Inc (EVLO) is -13,729.10 USD. This EVLO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.32 USD, the upside of Evelo Biosciences Inc is -4,337,888.30%.
Based on its market price of 0.32 USD and our intrinsic valuation, Evelo Biosciences Inc (EVLO) is overvalued by 4,337,888.30%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -13,729.10 - -13,729.10 | -13,729.10 | -4,337,888.30% |
| P/E | (18,671.58) - (31,247.43) | (23,682.70) | -7482784.6% |
| DDM - Stable | (10.65) - (24.54) | (17.60) | -5660.5% |
| DDM - Multi | (13.78) - (21.45) | (16.65) | -5359.8% |
| Market Cap (mil) | 0.01 |
| Beta | -0.98 |
| Outstanding shares (mil) | 0.03 |
| Enterprise Value (mil) | 16.61 |
| Market risk premium | 4.60% |
| Cost of Equity | 14,058.96% |
| Cost of Debt | 5.00% |
| WACC | 8.04% |